New NICE Guidelines – identification and management of adrenal insufficiency

The publication of new NICE (National Institute for Health and Care Excellence) guidelines – “Adrenal insufficiency: identification and management” marks a significant advancement in the management and treatment of primary, secondary and tertiary adrenal insufficiency.
These guidelines provide updated, evidence-based recommendations designed to improve diagnosis, treatment, and long-term care for individuals with adrenal insufficiency.
By setting clear standards, the new guidelines aim to enhance patient outcomes, ensure timely interventions, and reduce assoicated risks – including that of adrenal crisis.
Read the guidelines on the NICE website here.
Recent Blog Posts
What you should know about COVID-19 – updated 10th August 2021
Guidance from other organizations is continually being issued and we'll do our best to link to them below - please keep checking back here for more updates. UPDATE 10th August 2021 Article: “ChAdOx1 SARS‐CoV‐2 vaccination: A putative precipitant of adrenal crises”...
Drug shortage alert: injectable hydrocortisone
The Department of Health and Social Care (DHSC) has confirmed an upcoming shortage of hydrocortisone sodium phosphate for emergency injection kits from the end of February 2025, with supply expected to resume in May 2026. Find more information about this on the...
Survey: Lived experience & Quality of life
Call for participants - "Exploring the lived experiences and quality of life of individuals affected by CAH" If you're 18 years and over and living with CAH, tell us how CAH affects your life in an individual discussion held at a convenient time face-to-face or...
Survey: Paediatric Adrenal Insufficiency Education
This project, led by Edge Hill University is working with NHS clinicians to develop national education standards and resources for sick day/emergency management of adrenal insufficiency in children and young people. The project would like to hear the views of parents...